SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is DAG? In more traditional blockchains, the host provides the food/drinks (i.e resources) for this party. And when the guests arrive, the amount of resources can only accommodate so many people, the portions are small and then everything eventually runs out and the party ends. Think Constellation DAG like a potluck (a party where everyone brings food/drinks). With every added guest (node to the network), the more resources the party has to keep going. This is the nature of Constellation, a distributed system that scales horizontally.  Is Constellation a Blockchain? Not exactly. Although inspired by the principles of decentralization, many standard blockchains such as Bitcoin and Ethereum face scalability issues. This is why the next, generation of decentralized networks such as Hashgraph, IOTA, and Constellation have turned to DAG.  What is a Microservice? “Microservices” is an approach to application development in which a large application is built as a suite of modular services. Each module supports a specific business goal and uses a simple, well-defined interface to communicate with other sets of services. Uber, for example, is not a singular app purse. It is a unified app which means it is a single interface that brings together their driver app, their rider app, and their corporate team app.

Constellation

Constellation (DAG) is gaining significant attention following its expanded accessibility via a Kraken listing, broadening its reach into regulated markets. The community is actively discussing new strategic partnerships to scale its "Digital Evidence" product, highlighting its focus on providing cryptographically verified data integrity for enterprise, defense, and AI sectors as foundational Web3 infrastructure for real-world utility.

Zoracles

Zoracles (ZORA) is trending as the crypto community eagerly anticipates major market catalysts, including the Clarity Act and potential macroeconomic shifts like FED rate adjustments and government re-openings. Investors are actively discussing its strong connection to Coinbase's Base ecosystem and its potential in the creator economy and RWA tokenization, with many viewing it as a prime "buy the dip" opportunity for significant long-term growth despite short-term volatility.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is trending amid robust Q3 earnings and record cash flow, aligning with a broader surge in gold and silver prices driven by global geopolitical tensions and central bank demand. The community widely views Newmont as undervalued and anticipates a significant rally for the major gold and silver miner.

Almonty Industries, Inc. engages in mining, processing and shipment of tungsten concentrates. Its projects include Los Santos, Valtreixal, Almonty Korea Tungsten, Almonty Korea Moly, and Panasquiera. The company was founded on September 28, 2009 and is headquartered in Toronto, Canada.

Almonty Industries Inc

Almonty Industries is trending as recent reports indicate significant US government interest and potential investment in its tungsten projects, positioning it as a pivotal player in establishing a non-Chinese critical mineral supply chain. The community is actively discussing the imminent production from its Sangdong mine and strategic US asset acquisitions, highlighting ALM's crucial role in the defense and semiconductor sectors.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron is trending following several positive regulatory updates, including new FDA approvals for Eylea HD and Libtayo, alongside a robust Q3 earnings beat driven by strong Dupixent sales. While analyst upgrades and progress in gene therapy and rare disease pipelines fuel significant bullish sentiment, persistent concerns over third-party manufacturing issues continue to create market volatility and discussion among investors.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens (XLM) is trending following the live activation of its X-Ray privacy protocol on Mainnet, a significant development many in the community believe will accelerate institutional adoption and real-world asset (RWA) integration. Despite recent price fluctuations, holders are pointing to XLM's established connections with major financial institutions and its role in new blockchain consortia as strong indicators of its fundamental utility and future growth potential.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending due to significant advancements toward launching commercial electric air taxi services in Dubai by 2026 and plans to expand its U.S. manufacturing capacity. The community is actively debating its perceived leadership in FAA certification and growing defense sector involvement against concerns regarding its valuation and cash utilization.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending amidst intense public debate surrounding a recent incident involving federal immigration enforcement in Minneapolis, resulting in a citizen's death. Community discussions are highly polarized, with some condemning the event as an unjustified act and others defending law enforcement's actions against an alleged agitator. This controversy is fueling political tensions, particularly concerning government funding for the Department of Homeland Security, and contributing to broader market uncertainty.

Smith & Wesson Brands, Inc. is a holding company, which engages in the manufacture, design, and provision of firearms. Its portfolio includes handguns, long guns, handcuffs, suppressor, and other firearm-related products. The firm's brands are Smith & Wesson, M&P, Thompson/Center Arms, and Gemtech. The company was founded by Horace Smith and Daniel Baird Wesson in 1852 and is headquartered in Maryville, TN.

Smith & Wesson Brands Inc

Smith & Wesson Brands is a key focus as news circulates about potential loosening of U.S. firearm restrictions and relaxed export controls, fueling community speculation of increased demand amidst perceived civil unrest. While the stock has seen recent volatility following earnings misses, investors are actively debating its long-term potential given these shifting regulatory and societal dynamics.

Axe Compute, Inc. engages in the application of artificial intelligence medicine and the provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate. The Helomics segment includes contract services that include the application of AI, partnering projects, and clinical testing. The zPREDICTA segment specializes in organ-specific disease models that provide 3D reconstruction of human tissues accurately representing each disease state and mimicking drug response enabling accurate testing of anticancer agents. The Skyline segment consists of the STREAMWAY System product sales, and its TumorGenesis subsidiary is included within the Corporate segment. The Soluble segment provides services using an automated system that conducts self-interaction chromatography screens, using additives and excipients commonly included in protein formulations resulting in soluble and physically stable formulations for biologics. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA.

Axe Compute Inc.

Predictive Oncology Inc

Predictive Oncology Inc. is trending after announcing a significant private placement to initiate a digital asset treasury strategy focused on Aethir (ATH) tokens, signaling a strategic pivot towards high-performance AI infrastructure. This development, occurring alongside a reverse stock split and an impending ticker change to AGPU, has sparked intense debate among investors, with some anticipating a high-potential low-float crypto play while others express deep skepticism due to the company's history of dilution and previous business shifts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CytomX Therapeutics (NASDAQ:CTMX) Sets New 1-Year High - Should You Buy?

CytomX Therapeutics (NASDAQ:CTMX) Sets New 1-Year High - Here's Why...

CytomX Therapeutics (NASDAQ:CTMX) Shares Down 5.3% - Here's Why

CytomX Therapeutics (NASDAQ:CTMX) Trading Down 5.3% - Should You Sell...

Guggenheim Upgrades CytomX Therapeutics (NASDAQ:CTMX) to "Strong-Buy"

Guggenheim upgraded shares of CytomX Therapeutics to a "strong-buy" rating in a research note on Tuesday...

Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock?

Qiagen (QGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Average Recommendation of "Moderate Buy" from Brokerages

CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) has been given an average rating of "Moderate Buy" by the seven brokerages that are presently covering the stock, Marketbeat.com reports. One...

Formidable Asset Management LLC Sells 194,513 Shares of CytomX Therapeutics, Inc. $CTMX

Formidable Asset Management LLC reduced its position in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) by 62.2% in the third quarter, according to its most recent filing with the...

CytomX Stock Rises 31% in a Month: Here's What You Should Know

CTMX's share jumps 31% in a month after it outlined pipeline progress and 2026 goals led by Varseta-M in advanced colorectal cancer.

CytomX Therapeutics (NASDAQ:CTMX) Reaches New 12-Month High - Here's What Happened

CytomX Therapeutics (NASDAQ:CTMX) Hits New 12-Month High - Should You Buy...

CytomX Therapeutics (NASDAQ:CTMX) Hits New 1-Year High - Here's Why

CytomX Therapeutics (NASDAQ:CTMX) Hits New 52-Week High - Should You Buy...

237,081 Shares in CytomX Therapeutics, Inc. $CTMX Acquired by Precision Wealth Strategies LLC

Precision Wealth Strategies LLC bought a new position in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) during the third quarter, according to the company in its most recent 13F...

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

CytomX Therapeutics Inc

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

CTMX
CytomX Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CTMX News

CTMXCytomX Therapeutics Inc